Ovid Therapeutics Inc Sustainability Reports
Ovid Therapeutics Inc. is a biopharmaceutical company dedicated to developing targeted small molecule therapies for rare neurological disorders and epilepsies.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300H36NUI4L6U8F17
FIGI: BBG009F0TD85
8 reports from 2017 to 2025
